Head-to-head · WeighScore
Hims & Hers vs MANÜ Telehealth
The verdict
Hims & Hers takes it — 81/100 to 72.2/100.
Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Hims & Hers | MANÜ Telehealth |
|---|---|---|
| WeighScore | 81/100 | 72.2/100 |
| Grade | B− | C |
| Scorecard rank | #36 | #83 |
| Semaglutide | $199/mo | $120/mo (compounded) |
| Tirzepatide | Not disclosed | $150/mo (compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #36 · B−
Strengths
- Nationwide
- Polished app
- Strong brand trust
Where it loses points
- Tirzepatide pricing inconsistently disclosed
- Industry-wide compounding scrutiny
Graded #83 · C
Strengths
- Compounded GLP-1s advertised from about $4-$5/day
- 100% online with free discreet shipping and no insurance needed
- Compounds exclusively from US 503A pharmacies
- Add-on options like MIC Ultraburn and NAD+
Where it loses points
- Per-dose pricing is gated behind login/signup, not public
- State availability changes and is only confirmed at signup
- Compounded medications are not FDA-evaluated
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.